Search: onr:"swepub:oai:gup.ub.gu.se/121218" >
Exenatide affected ...
Exenatide affected circulating cardiovascular risk biomarkers independently of changes in body composition
-
Bunck, M. C. (author)
-
Diamant, M. (author)
-
- Eliasson, Björn, 1959 (author)
- Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine
-
show more...
-
Corner, A. (author)
-
Shaginian, R. M. (author)
-
Heine, R. J. (author)
-
Taskinen, Marja-Riitta (author)
-
Yki-Järvinen, Hannele (author)
-
- Smith, Ulf, 1943 (author)
- Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine
-
show less...
-
(creator_code:org_t)
- 2010
- 2010
- English.
-
In: Diabetes Care. - 0149-5992. ; 33:8, s. 1734-1737
- Related links:
-
https://gup.ub.gu.se...
Abstract
Subject headings
Close
- OBJECTIVE To study the effect of exenatide on body composition and circulating cardiovascular risk biomarkers. RESEARCH DESIGN AND METHODS Metformin-treated patients with type 2 diabetes (N = 69) were randomized to exenatide or insulin glargine and treated for 1 year. Body composition was evaluated by dual-energy X-ray absorptiometry. Additionally, body weight, waist circumference, and cardiovascular biomarkers were measured. RESULTS Treatment with exenatide for 1 year significantly reduced body weight, waist circumference, and total body and trunkal fat mass by 6, 5, 11, and 13%, respectively. In addition, exenatide increased total adiponectin by 12% and reduced high-sensitivity C-reactive protein by 61%. Insulin glargine significantly reduced endothelin-1 by 7%. These changes were statistically independent of the change in total body fat mass and body weight. CONCLUSIONS Exenatide treatment for 1 year reduced body fat mass and improved the profile of circulating biomarkers of cardiovascular risk. No significant changes were seen with insulin glargine except a trend for reduced endothelin-1 levels.
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database
- By the author/editor
-
Bunck, M. C.
-
Diamant, M.
-
Eliasson, Björn, ...
-
Corner, A.
-
Shaginian, R. M.
-
Heine, R. J.
-
show more...
-
Taskinen, Marja- ...
-
Yki-Järvinen, Ha ...
-
Smith, Ulf, 1943
-
show less...
- Articles in the publication
-
Diabetes Care
- By the university
-
University of Gothenburg